P

Inventor

FINKE PAUL E

46 patents
⚠️ This page may combine multiple inventors who share the name “FINKE PAUL E”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

MERCK & CO INC

41 patents
US5719147AFeb 17, 1998

Morpholine and thiomorpholine tachykinin receptor antagonists

MERCK & CO INC193 citations99
US5637699AJun 10, 1997

Process for preparing morpholine tachykinin receptor antagonists

MERCK & CO INC85 citations96
US5387595AFeb 7, 1995

Alicyclic compounds as tachykinin receptor antagonists

MERCK & CO INC72 citations96
US5229381AJul 20, 1993

Substituted azetidinones as anti-inflammatory and antidegenerative agents

MERCK & CO INC57 citations96
US6235735B1May 22, 2001

Morpholine and thiomorpholine tachykinin receptor antagonists

MERCK & CO INC19 citations93
US6048859AApr 11, 2000

Morpholine and thiomorpholine tachykinin receptor antagonists

MERCK & CO INC26 citations93
US6538002B1Mar 25, 2003

Cyclopentyl modulators of chemokine receptor activity

MERCK & CO INC22 citations92
US6140349AOct 31, 2000

Cyclic amine modulators of chemokine receptor activity

MERCK & CO INC44 citations92
US6136827AOct 24, 2000

Cyclic amine modulations of chemokine receptor activity

MERCK & CO INC52 citations92
US5607936AMar 4, 1997

Substituted aryl piperazines as neurokinin antagonists

MERCK & CO INC42 citations92
US4623645ANov 18, 1986

Substituted cephalosporin sulfoxides as anti-inflammatory and antidegenerative agents

MERCK & CO INC26 citations92
US4547371AOct 15, 1985

Substituted cephalosporin sulfones as anti-inflammatory and anti-degenerative agents

MERCK & CO INC56 citations92
US6432981B1Aug 13, 2002

Cyclopentyl modulators of chemokine receptor activity

MERCK & CO INC36 citations91
US5348953ASep 20, 1994

Substituted azetidinones as anti-inflammatory and antidegenerative agents

MERCK & CO INC39 citations91
US7271266B2Sep 18, 2007

Substituted 2,3-diphenyl pyridines

MERCK & CO INC21 citations84
US6506777B1Jan 14, 2003

Cyclopentyl modulators of chemokine receptor activity

MERCK & CO INC15 citations84
US5591737AJan 7, 1997

Substituted azetidinones as anti-inflammatory and antidegenerative agents

MERCK & CO INC18 citations84
US5364848ANov 15, 1994

Substituted cephalosporin sulfones as anti-inflammatory and antidegenerative agents

MERCK & CO INC16 citations82
US6500844B1Dec 31, 2002

Cyclopentyl modulators of chemokine receptor activity

MERCK & CO INC13 citations74
US5872116AFeb 16, 1999

Morpholine and thiomorpholine tachykinin receptor antagonists

MERCK & CO INC14 citations74
US4845088AJul 4, 1989

Tetrazolyl derivatives of beta-lactams useful as elastase inhibitors

MERCK & CO INC10 citations74
US4699904AOct 13, 1987

Tetrazolyl derivatives of β-lactams useful as elastase inhibitors

MERCK & CO INC12 citations74
US7057051B2Jun 6, 2006

Substituted imidazoles as cannabinoid receptor modulators

MERCK & CO INC7 citations73
US6479518B2Nov 12, 2002

Zwitterionic tachykinin receptor antagonists

MERCK & CO INC11 citations73
US6476054B1Nov 5, 2002

Cyclic amine modulators of chemokine receptor activity

MERCK & CO INC10 citations73
US5132301AJul 21, 1992

Substituted cephalosporin sulfones as anti-inflammatory and anti-degenerative agents

MERCK & CO INC8 citations73
US4711886ADec 8, 1987

β-lactam derivatives as anti-inflammatory and antidegenerative agents

MERCK & CO INC10 citations73
US6358979B1Mar 19, 2002

N-cyclopentyl modulators of chemokine receptor activity

MERCK & CO INC12 citations72
US4637999AJan 20, 1987

Substituted cephalosporins as anti-inflammatory and antidegenerative agents

MERCK & CO INC16 citations72
US4797396AJan 10, 1989

β-Lactam derivatives as anti-inflammatory and antidegenerative agents

MERCK & CO INC9 citations70
US6638930B2Oct 28, 2003

Morpholine and thiomorpholine tachykinin receptor antagonists

MERCK & CO INC1 citations63
US5276139AJan 4, 1994

Haptens useful in evaluating inhibition of PNN elastase by N-substituted azetidinones

MERCK & CO INC2 citations63
US7196113B2Mar 27, 2007

Lactam tachykinin receptor antagonists

MERCK & CO INC2 citations62
US6472410B1Oct 29, 2002

N-cyclopentyl modulators of chemokine receptor activity

MERCK & CO INC4 citations62
US4847247AJul 11, 1989

Penicillin derivatives as anti-inflammatory and antidegenerative agents

MERCK & CO INC7 citations62
US6593346B2Jul 15, 2003

N-cyclopentyl modulators of chemokine receptor activity

MERCK & CO INC3 citations61
US5420010AMay 30, 1995

Assay for evaluating inhibition of polymorphonuclear leukocyte elastase by N-substituted azetidinones

MERCK & CO INC2 citations60
US7572785B2Aug 11, 2009

Substituted imidazoles as cannabinoid receptor modulators

MERCK & CO INC1 citations52
US5391819AFeb 21, 1995

Process of making chiral 2-aryl-1,4-butanediamine derivatives as useful neurokinin-A antagonists

MERCK & CO INC0 citations52
US4380645AApr 19, 1983

Process for preparing Benzoxepino- or Benzthiapino[4,3-b]pyrrole-2-acetic acids

MERCK & CO INC1 citations51
US7091211B2Aug 15, 2006

Cyclopentyl modulators of chemokine receptor activity

MERCK & CO INC0 citations36

WALSH SHAWN

1 patent

MERCK SHARP & DOHME

1 patent

LIANG GUI-BAI

1 patent

DUFFY JOSEPH L

1 patent

DALE DAVID C

1 patent